In response to the need of an aging population driven to lead a more active and independent life, Orthometrix, Inc. (OTC-BB: OMRX) has developed technologies, procedures and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with Osteoarthritis, Plantar Fasciitis and other musculoskeletal conditions which reduce mobility.

Headquartered in White Plains, New York Orthometrix markets, sells and services through its Healthcare Division (i) peripheral Quantitative Computed Tomography (pQCT) bone and muscle measurement systems for research and clinical applications, (ii) patented motorized exercise systems for rehabilitation, physical therapy and sports medicine based on patented vibration technoloy (VibraFlex, Mini VibraFlex and Galileo series), (iii) human performance measurement systems for monitoring improvement in power and mobility (Leonardo system) and (iv) Extracorporeal Shock Wave Therapy (ESWT) systems for non-invasive treatment of pain associated with Plantar Fasciitis (Orbasone sytem). The Company also markets, sells and services through its Sports & Fitness Division patented motorized exercise systems to professional teams, fitness centers, gyms, sports clubs and to wellness-conscious general public (VibraFlex 500 and Mini VibraFlex series).